Report for Walczak M

General

Full name :

First name :

Mail :

Zip Code :

City :

Country :

Email :

Phone :

Fax :

Website :

Directory :

References (5)

Title : Discovery of new, highly potent and selective inhibitors of BuChE - Design, synthesis, in vitro and in vivo evaluation and crystallography studies - Panek_2023_Eur.J.Med.Chem_249_115135
Author(s) : Panek D , Pasieka A , Latacz G , Zareba P , Szczech M , Godyn J , Chantegreil F , Nachon F , Brazzolotto X , Skrzypczak-Wiercioch A , Walczak M , Smolik M , Salat K , Hofner G , Wanner K , Wieckowska A , Malawska B
Ref : Eur Journal of Medicinal Chemistry , 249 :115135 , 2023
Abstract : Panek_2023_Eur.J.Med.Chem_249_115135
ESTHER : Panek_2023_Eur.J.Med.Chem_249_115135
PubMedSearch : Panek_2023_Eur.J.Med.Chem_249_115135
PubMedID: 36696766
Gene_locus related to this paper: human-BCHE

Title : Development and crystallography-aided SAR studies of multifunctional BuChE inhibitors and 5-HT6R antagonists with beta-amyloid anti-aggregation properties - Wichur_2021_Eur.J.Med.Chem_225_113792
Author(s) : Wichur T , Godyn J , Goral I , Latacz G , Bucki A , Siwek A , Gluch-Lutwin M , Mordyl B , Sniecikowska J , Walczak M , Knez D , Jukic M , Salat K , Gobec S , Kolaczkowski M , Malawska B , Brazzolotto X , Wieckowska A
Ref : Eur Journal of Medicinal Chemistry , 225 :113792 , 2021
Abstract : Wichur_2021_Eur.J.Med.Chem_225_113792
ESTHER : Wichur_2021_Eur.J.Med.Chem_225_113792
PubMedSearch : Wichur_2021_Eur.J.Med.Chem_225_113792
PubMedID: 34530376
Gene_locus related to this paper: human-BCHE

Title : Rational design of new multitarget histamine H(3) receptor ligands as potential candidates for treatment of Alzheimer's disease - Lazewska_2020_Eur.J.Med.Chem_207_112743
Author(s) : Lazewska D , Bajda M , Kaleta M , Zareba P , Doroz-Plonka A , Siwek A , Alachkar A , Mogilski S , Saad A , Kuder K , Olejarz-Maciej A , Godyn J , Stary D , Sudol S , Wiecek M , Latacz G , Walczak M , Handzlik J , Sadek B , Malawska B , Kiec-Kononowicz K
Ref : Eur Journal of Medicinal Chemistry , 207 :112743 , 2020
Abstract : Lazewska_2020_Eur.J.Med.Chem_207_112743
ESTHER : Lazewska_2020_Eur.J.Med.Chem_207_112743
PubMedSearch : Lazewska_2020_Eur.J.Med.Chem_207_112743
PubMedID: 32882609

Title : Perspective of SGLT2 Inhibition in Treatment of Conditions Connected to Neuronal Loss: Focus on Alzheimer's Disease and Ischemia-Related Brain Injury - Wicinski_2020_Pharmaceuticals.(Basel)_13_
Author(s) : Wicinski M , Wodkiewicz E , Gorski K , Walczak M , Malinowski B
Ref : Pharmaceuticals (Basel) , 13 : , 2020
Abstract : Wicinski_2020_Pharmaceuticals.(Basel)_13_
ESTHER : Wicinski_2020_Pharmaceuticals.(Basel)_13_
PubMedSearch : Wicinski_2020_Pharmaceuticals.(Basel)_13_
PubMedID: 33187206

Title : Pharmacogenetics of Cannabinoids - Hryhorowicz_2018_Eur.J.Drug.Metab.Pharmacokinet_43_1
Author(s) : Hryhorowicz S , Walczak M , Zakerska-Banaszak O , Slomski R , Skrzypczak-Zielinska M
Ref : Eur J Drug Metab Pharmacokinet , 43 :1 , 2018
Abstract : Hryhorowicz_2018_Eur.J.Drug.Metab.Pharmacokinet_43_1
ESTHER : Hryhorowicz_2018_Eur.J.Drug.Metab.Pharmacokinet_43_1
PubMedSearch : Hryhorowicz_2018_Eur.J.Drug.Metab.Pharmacokinet_43_1
PubMedID: 28534260